Core Insights - VB Spine has successfully acquired the U.S. spine business from Stryker and will operate as a standalone entity [1] - The company is advancing towards completing the acquisition of Stryker's international spine businesses, pending legal and regulatory requirements [2] - VB Spine aims to enhance patient outcomes through innovative technology solutions and a strong focus on operational excellence [3] Company Overview - VB Spine is the largest privately held spine company and among the largest family-owned medical technology companies globally [8] - The company is led by Marc, John, and Anthony Viscogliosi, who are co-founders of Viscogliosi Brothers, LLC [3][8] - VB Spine has access to Stryker's Mako Spine and Copilot, which will support its growth and improve surgical precision [6] Strategic Goals - VB Spine is dedicated to addressing critical needs in spine surgery and improving patient care through a comprehensive product portfolio and strong distribution network [3][8] - The company is focused on expanding its reach to serve surgeons and patients globally, emphasizing a patient-first approach [2][3] - VB Spine's leadership believes that their commitment to innovation and collaboration will drive transformation in spine surgery [4]

Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC. Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve ...

Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company’s board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025. Manny brings more than 30 years of experience leading high-performing organizations and advising senior executives on large-scale corporate transformations. He currently serves as Chairman of Bain & Company, following his tenure as Worldwide Managing Partn ...

Core Points - Stryker has scheduled its 2025 Annual Meeting of Shareholders for May 8, 2025, at 9:30 a.m. Eastern Time, to be held virtually [1] - A recording of the annual meeting will be available from May 9, 2025, at 10:30 a.m. Eastern Time until the filing of the definitive proxy statement for the 2026 Annual Meeting [2] - Stryker is a global leader in medical technologies, impacting over 150 million patients annually with innovative products and services in MedSurg, Neurotechnology, and Orthopaedics [3] Company Information - Stryker offers a range of medical technologies aimed at improving healthcare outcomes [3] - The company provides contact information for investor and media inquiries, indicating a structured approach to communication [4]

合作伙伴征集：2025全球手术机器人大会 报名：首届全球眼科大会 | 暂定议程 报名：首届全球心血管大会 | 奖项报名倒计时 报名：首届全球骨科大会 | 奖项报名倒计时 2025年3月15日上午，2025中国医学装备大会在重庆悦来国际会议中心成功召开。相关政府部门领导、知名院士、医疗机构专家，研发生产企业、高校、科 研院所、投融资机构负责人等嘉宾出席大会。 中国医学装备协会理事长 侯岩介绍， 2024年中国医学装备市场规模达到 1.35万亿 元，同比增长 6％ 左右 。据了解，目前我国已形成22个大类1100多个 品类的产品体系，是世界上产品类别和品种最齐全的国家之一，产品广泛服务于临床应用，覆盖卫生健康各个领域。 目前大会已圆满落幕。本届展会中，哪些企业凭借创新亮相引起了行业关注？又有哪些前沿产品和技术成为焦点？思宇将全面回顾展会精彩亮点，供各位读 者参考。 # 美敦力 美敦力在本届大会上展出 近80款 全球创新产品， 包括 全球首发的PulseSelect一次性心脏脉冲场消融导管 ，以及多款前沿技术产品， 其中不乏首次展出及近 期获批的产品和技术。 其中包括中国首款获批的 PulseSelect一次性心脏 ...

Latest technology offers more applications and innovation across more specialtiesMAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics ...

Core Insights - Inari Medical, now part of Stryker, has launched the Artix Thrombectomy System, designed specifically for the peripheral arterial system, aiming to set a new standard for arterial thrombectomy [1][2][4] Product Overview - The Artix Thrombectomy System combines aspiration and mechanical thrombectomy, providing procedural control and versatility for treating arterial blood clots [1][2] - It is Inari's first product targeting the arterial space, building on the success of its venous thrombectomy devices [2][4] Clinical Significance - The system addresses a critical clinical need for effective treatment of chronic thrombi and aims to reduce the risk of clot migration [4] - Dr. Jonathan Bowman, who performed the first commercial case, highlighted its effectiveness in managing a wide range of clots while maintaining vessel access [3][4] Key Features - The Artix system includes a dual mechanical thrombectomy and aspiration toolkit, designed to remove acute to chronic clots in a single session [7] - It features an 8 Fr. low profile, trackable, kink-resistant sheath available in 65cm and 90cm lengths, enhancing treatment options for complex interventions [7] - The innovative over-the-wire mechanical element is designed to effectively collect and retrieve clots, while a covered nitinol mesh funnel minimizes the risk of arterial clot migration during procedures [7][9] Company Background - Stryker, a global leader in medical technologies, acquired Inari Medical on February 19, 2025, to enhance its portfolio in treating venous and arterial diseases [5][4] - Stryker impacts over 150 million patients annually through its innovative products and services across various medical fields [4]

Core Insights - Stryker has launched the Steri-Shield 8 personal protection system, enhancing its leadership in medical technologies and personal protective equipment [1][2] - The launch aligns with Stryker's strategy of continuous innovation and complements its existing product portfolio [1][2] Product Features and Benefits - Steri-Shield 8 features a customizable helmet with a secure fit and a ponytail path for long-haired users, enhancing comfort and usability [4] - The helmet offers a 22% wider field of vision and improved lighting compared to previous versions, along with a targeted cooling system for user comfort [4][5] - The system includes AAMI Level 4 protection, providing the highest fluid and microbial barrier for healthcare professionals [5] Market Performance - Stryker's shares declined by 1.3% following the launch, influenced by broader market weakness, while the company’s shares have increased by 6.6% year-to-date, outperforming the industry [3] - The S&P 500 Index has seen a decline of 0.9% during the same period [3] Financial Performance - In Q4 2024, Stryker reported revenues of $6.44 billion, a 10.7% year-over-year increase, with an adjusted EPS of $4.01, exceeding market expectations [9] - The company achieved organic sales growth of 10.2%, particularly strong in Instruments, Endoscopy, and Trauma & Extremities segments [9] Strategic Focus - Stryker's recent divestiture of its Spinal Implants business allows for a focus on high-growth areas such as interventional spine and enabling technologies [10] - The acquisition of Inari Medical signifies Stryker's commitment to expanding into high-potential medical markets [10] Complementary Innovations - The Steri-Shield 8 launch complements Stryker's existing MedSurg and Neurotechnology segments, particularly in Instruments and Endoscopy, which have shown strong performance [6] - Recent innovations like the Pangia plating system and LIFEPAK 35 defibrillator have also driven market interest, supporting Stryker's focus on safety and efficiency [8]

Core Insights - Stryker has launched the Steri-Shield 8 personal protection system, enhancing safety and wearability for healthcare professionals [1][2] - The system includes a customizable helmet, a sleeker battery, an efficient charging station, and three toga styles [2] Product Features - The helmet features three points of contact for an adjustable fit and includes a ponytail path for long-haired users [4] - Enhanced visibility is provided with a brighter helmet light and a 22% wider field of vision compared to the previous generation [4] - The fan design targets the front and back of users' necks to maintain comfort [4] - The togas offer AAMI level 4 protection, ensuring the highest fluid and microbial barrier for healthcare professionals [4] Company Overview - Stryker is a global leader in medical technologies, impacting over 150 million patients annually through innovative products and services in MedSurg, Neurotechnology, and Orthopaedics [3]

Core Insights - Stryker has launched the Sync Badge, a hands-free, wearable communication device aimed at improving collaboration among healthcare team members in patient care settings [1][2][3] Product Features - The Sync Badge enables voice command functionality, allowing care team members to connect with each other across different units and roles, facilitating quick and reliable communication [2][3] - It includes a dedicated panic button for emergencies, enabling team members to quickly request help while providing security personnel with the staff member's name and location [8] - The device features a Do Not Disturb (DND) mode, allowing users to focus on critical tasks while still being able to receive urgent calls if necessary [8] - Integration capabilities with various connected devices and software platforms allow the Sync Badge to receive alarms and critical notifications directly, enhancing workflow efficiency [8][9] Market Context - The introduction of the Sync Badge comes at a time when nursing shortages are prevalent, and healthcare environments are increasingly demanding, highlighting the need for tools that simplify workflows and enhance communication [3][4] - Stryker positions itself as a leader in medical technologies, impacting over 150 million patients annually through innovative products and services [6]